Author details

Full Name

Victor R Gordeuk

Affiliation

ORCID

Career Start Year

1985

Papers

394

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37350061	Vaccination in sickle cell disease: Immunocompromised or immunocompetent?		2023
36399516	Genome-wide meta-analysis identifies new candidate genes for sickle cell disease nephropathy.	Blood Adv	2023
37662265	WHOLE GENOME SEQUENCING ANALYSIS OF BODY MASS INDEX IDENTIFIES NOVEL AFRICAN ANCESTRY-SPECIFIC RISK ALLELE.	medRxiv	2023
37738155	A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease.	Blood Adv	2023
37553354	Gene expression changes in sickle cell reticulocytes and their clinical associations.	Sci Rep	2023
36971592	In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction.	Am J Hematol	2023
37206276	Community-level socioeconomic distress is associated with nutritional status in adults with sickle cell anemia.		2023
36824724	<i>In vivo</i> evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction.	bioRxiv	2023
36819151	Predictors and clinical complications associated with antiphospholipid antibodies in sickle cell disease.		2023
37456969	Burden of Aging: Health Outcomes Among Adolescents and Young Adults With Sickle Cell Disease.	Hemasphere	2023
36634264	Use of multiple urinary biomarkers for the early detection of chronic kidney disease in sickle cell anemia.		2023
37066337	Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients, as a function of therapeutic transfusion and hydroxyurea treatment.	bioRxiv	2023
37007990	Metabolic correlates to critical speed in murine models of sickle cell disease.	Front Physiol	2023
36628629	How do we operate a large monthly red blood cell exchange program.	Transfusion	2023
36623746	Associations of hemolysis and anemia with cardiopulmonary dysfunction in an adult sickle cell disease cohort.		2023
37439373	Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment.	Haematologica	2023
37248069	Platelet count decline and high neutrophil count within the first day of admission for painful sickle cell vaso-occlusive episodes predict severe complications.		2023
37057750	Infertility and treatment-seeking practices among females and males with sickle cell disease in the Sickle Cell Disease Implementation Consortium registry.	Pediatr Blood Cancer	2023
37435906	Increased transferrin protects from thrombosis in Chuvash erythrocytosis.		2023
36993312	Genetic regulation of fetal hemoglobin across global populations.	medRxiv	2023
36925803	Evaluating the implementation of a multi-level mHealth study to improve hydroxyurea utilization in sickle cell disease.	Front Health Serv	2023
36602125	Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci.	Br J Haematol	2023
37101805	is a candidate gene in sickle cell disease-associated pulmonary hypertension and pulmonary arterial hypertension.		2023
36980912	What We Know and What We Do Not Know about Evolutionary Genetic Adaptation to High Altitude Hypoxia in Andean Aymaras.		2023
35156191	Voxelotor and albuminuria in adults with sickle cell anaemia.	British Journal of Haematology	2022
35445915	An evaluation of patient-reported outcomes in sickle cell disease within a conceptual model.	Qual Life Res	2022
35759756	Improvement of hemolytic anemia with GBT1118 is renoprotective in transgenic sickle mice.	Blood advances	2022
36006620	Haptoglobin 1 allele predicts higher serum haptoglobin concentration and lower multiorgan failure risk in sickle cellÂ disease.	Blood advances	2022
35927319	Rare genetic variants explain missing heritability in smoking.	Nat Hum Behav	2022
36058234	COVID-19 vaccination status and disease burden in patients with sickle cell disease.	British Journal of Haematology	2022
35721605	Hyperkalemia and Metabolic Acidosis Occur at a Higher eGFR in Sickle Cell Disease.	Kidney360	2022
34151594	Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease.	Annals of Pharmacotherapy	2022
34929051	Thrombomodulin and multiorgan failure in sickle cell anemia.	American Journal of Hematology	2022
35142007	Pregnancy outcomes with hydroxyurea use in women with sickle cell disease.	Am J Hematol	2022
34375971	Urinary Kringle Domain-Containing Protein HGFL: A Validated Biomarker of Early Sickle Cell Anemia-Associated Kidney Disease.	Am J Nephrol	2021
34014839	Multiple-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage.	J Clin Invest	2021
33956067	HIF-2 inhibitor, erythrocytosis, and pulmonary hypertension.	Blood	2021
34268729	Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study.	British Journal of Haematology	2021
33570644	Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection.	Blood advances	2021
33988517	Comparing the Effectiveness of Education Versus Digital Cognitive Behavioral Therapy for Adults With Sickle Cell Disease: Protocol for the Cognitive Behavioral Therapy and Real-time Pain Management Intervention for Sickle Cell via Mobile Applications (CaRISMA) Study.	JMIR Res Protoc	2021
34095734	Evaluation of point-of-care International Normalized Ratio in sickle cell disease.	Research and Practice in Thrombosis and Haemostasis	2021
34350622	Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease.	Am J Hematol	2021
34131897	Time to rethink haemoglobin threshold guidelines in sickle cell disease.	Br J Haematol	2021
33121239	Antimicrobial resistance is a risk factor for mortality in adults with sickle cell disease.	Haematologica	2021
33216373	Engulfment and cell motility 1 (ELMO1) and apolipoprotein A1 (APOA1) as candidate genes for sickle cell nephropathy.	Br J Haematol	2021
33108017	Identifying adolescent and young adult patients with sickle cell disease at highest risk of death.	Am J Hematol	2021
34626431	Exercise-induced changes of vital signs in adults with sickle cell disease.	Am J Hematol	2021
34611900	Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.	Br J Haematol	2021
34604839	Effects of Renin-Angiotensin Blockade and on Kidney Function in Sickle Cell Disease.		2021
34714833	Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium.	PLoS One	2021